Prophylactic Add-on Antiplatelet Therapy in Chronic Kidney Disease With Type 2 Diabetes Mellitus: Comparison Between Clopidogrel and Low-dose Aspirin.

Int J Prev Med · 2013 · PMC3775167 · PMID 24049616

Europe PMC

hedged sentence

0.0080

closest p · 0.2× alpha

0.0080

boldest claim

The sentences

highly significantP = 0.008actually significant

The changes of the individual group were tested for significance and the percentage change in clopidogrel group was found to be highly significant ( P = 0.008) over aspirin group.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.